CANSF
Price:
$0.056
Market Cap:
$11.29M
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
CANSF
According to Willow Biosciences Inc.’s latest financial reports and current stock price. The company's current ROE is -325.63%. This represents a change of -146.43% compared to the average of 701.32% of the last 4 quarters.
The mean historical ROE of Willow Biosciences Inc. over the last ten years is 687.86%. The current -325.63% ROE has changed -147.34% with respect to the historical average. Over the past ten years (40 quarters), CANSF's ROE was at its highest in in the June 2024 quarter at 3.07%. The ROE was at its lowest in in the September 2020 quarter at -209.38%.
Average
687.86%
Median
-76.54%
Minimum
-379.19%
Maximum
6.07%
Discovering the peaks and valleys of Willow Biosciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 337.36%
Maximum Annual ROE = 6.07%
Minimum Annual Increase = -3098.92%
Minimum Annual ROE = -379.19%
Year | ROE | Change |
---|---|---|
2023 | -379.19% | 319.12% |
2022 | -90.47% | 337.36% |
2021 | -20.69% | -100.34% |
2020 | 6.07% | -3098.92% |
2019 | -202.49% | 2.82% |
2018 | -196.95% | -115.38% |
2018 | 1.28% | 110.74% |
2017 | 607.76% | -566.83% |
2016 | -130.19% | 107.94% |
2015 | -62.61% | -35.18% |
The current ROE of Willow Biosciences Inc. (CANSF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-163.45%
5-year avg
1.08%
10-year avg
687.86%
Willow Biosciences Inc.’s ROE is greater than Willow Biosciences Inc. (-325.63%), greater than Avicanna Inc. (-6184.19%), greater than Cansortium Inc. (-153.48%), greater than C21 Investments Inc. (-14.98%), greater than Heritage Cannabis Holdings Corp. (-54.53%),
Company | ROE | Market cap |
---|---|---|
-325.63% | $11.54M | |
-6184.19% | $20.38M | |
-153.48% | $32.15M | |
-14.98% | $23.17M | |
-54.53% | $3.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Willow Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Willow Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Willow Biosciences Inc.'s ROE?
How is the ROE calculated for Willow Biosciences Inc. (CANSF)?
What is the highest ROE for Willow Biosciences Inc. (CANSF)?
What is the 3-year average ROE for Willow Biosciences Inc. (CANSF)?
What is the 5-year average ROE for Willow Biosciences Inc. (CANSF)?
How does the current ROE for Willow Biosciences Inc. (CANSF) compare to its historical average?